CD4 and neoplasm: CD4 depletion also abolished an increase in the effector CD8+ T cells in DLN and total and MC38 (AdpgkMUT)-specific CD8+ T cells in tumor by Bpmel-OVAI-Ea cell adjuvant therapy (Fig. 3 D; and Fig. S4, E and F).